| Q38148620 | Assessment of target organ damage in the evaluation and follow-up of hypertensive patients: where do we stand? |
| Q45108163 | Association of heart rate and left ventricular structure in a rural population in Korea |
| Q36543089 | Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension |
| Q33559608 | Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension |
| Q37555936 | Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. |
| Q45184853 | Cardiovascular morbidity and mortality and left ventricular geometric patterns in hypertensive patients treated in primary care. |
| Q37853841 | Cardiovascular risk in subjects with left ventricular concentric remodeling at baseline examination: a meta-analysis |
| Q36446320 | Comparative effectiveness of antihypertensive treatment for older children with primary hypertension: study protocol for a series of n-of-1 randomized trials |
| Q38243510 | Congenital left ventricular outpouchings: a systematic review of 839 cases and introduction of a novel classification after two centuries |
| Q35640831 | Contrast stress echocardiography in hypertensive heart disease |
| Q45182782 | Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study |
| Q40110185 | Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study |
| Q54417730 | Determinants of systolic blood pressure response during exercise in overweight subjects. |
| Q40715496 | Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis |
| Q88106537 | Do we understand the relationship between left ventricular structural remodeling and stroke in arterial hypertension? |
| Q50074733 | Echocardiographic left ventricular reverse remodeling after 18 months of antihypertensive treatment in stage I hypertension. Results from the PREVER-treatment study |
| Q30250365 | Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic |
| Q47204125 | Favorable changes in arterial elasticity, left ventricular mass, and diastolic function after significant weight loss following laparoscopic sleeve gastrectomy in obese individuals |
| Q30444223 | Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging |
| Q39317074 | Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study |
| Q51834147 | Impact of age on left ventricular geometry and diastolic function in elderly patients with treated hypertension. |
| Q51240033 | Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study). |
| Q64062233 | Impact of medical therapy for cardiovascular disease on left ventricular diastolic properties and remodeling |
| Q37041769 | Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients |
| Q35688935 | Left Ventricular Geometry on Transthoracic Echocardiogram and Prognosis after Lacunar Stroke: The SPS3 Trial. |
| Q41103777 | Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network) |
| Q48791707 | Left ventricular function in children and adults after renal transplantation in childhood |
| Q37434977 | Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction |
| Q50533707 | Liver growth factor treatment restores cell-extracellular matrix balance in resistance arteries and improves left ventricular hypertrophy in SHR. |
| Q33574185 | Myocardial deformation in aortic valve stenosis: relation to left ventricular geometry |
| Q38209968 | Myocardial remodeling in hypertension |
| Q49607622 | Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertensio |
| Q91331127 | Obesity and its cardiovascular effects |
| Q38385756 | Obesity and left ventricular hypertrophy: the hypertension connection |
| Q38492359 | Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications |
| Q64112459 | Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients |
| Q64117288 | Pre-Transplant Left Ventricular Geometry and Major Adverse Cardiovascular Events After Kidney Transplantation |
| Q43936948 | Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania |
| Q34316673 | Prevalence and risk factors of abnormal left ventricular geometrical patterns in untreated hypertensive patients |
| Q37041667 | Prevalence of residual left ventricular structural changes after one year of antihypertensive treatment in patients of African descent: role of 24-hour pulse pressure |
| Q56970710 | Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document |
| Q36287921 | Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis |
| Q36955565 | Relationship between body composition and left ventricular geometry using three dimensional cardiovascular magnetic resonance. |
| Q90705209 | Renal Artery Denervation Due to Refractory Hypertension in a Patient After Kidney Transplantation-3 Years of Observation: A Case Report |
| Q37238169 | Sex Differences in the Associations of Hemodynamic Load With Left Ventricular Hypertrophy and Concentric Remodeling |
| Q38262422 | Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta |
| Q42003531 | Systolic blood pressure values might further risk-stratify the adverse outcomes of LVH in older patients with chronic kidney disease |
| Q34831733 | The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design |
| Q26781681 | The adrenergic system in pulmonary arterial hypertension: bench to bedside (2013 Grover Conference series) |
| Q38533878 | The paradox of obesity cardiomyopathy and the potential for weight loss as a therapy |
| Q36366106 | The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study |
| Q83181149 | Toll-like receptor 6 Ser249Pro polymorphism is associated with lower left ventricular wall thickness and inflammatory response in hypertensive women |